Abstract
Optical aggregometry by 96-well plate assay, the microplate method, is a fast, efficient, and readily available method for measuring the pharmacological effects of antiplatelet drugs. Even though recent years have witnessed growing interest in adopting the microplate method for widespread use, it remains in the shadow of the standard light transmission aggregometry (LTA). Regardless of the method used, the results of platelet aggregation depend on a variety of factors and often vary among laboratories worldwide. While several methodological papers have examined the microplate method, no standards have been established, most likely because the approach is not used as a diagnostic tool. Currently, the microplate method is recommended by researchers to be used in conjunction with LTA or as an adjunct to LTA. This raises the question of whether an optimal protocol exists for microplate aggregometry, and what are the key considerations in a good experimental protocol for obtaining reliable results? This article attempts to address these questions by summarizing the knowledge accumulated in this field over the last three decades.
Similar content being viewed by others
Data availability
Data presented in Fig. 1 are available from the corresponding author upon reasonable request.
Abbreviations
- 4PL:
-
4-parameter logistic model
- AA:
-
Arachidonic acid
- ADP:
-
Adenosine 5’-diphosphate
- ATP release assay:
-
Adenosine 5′-triphosphate release assay
- EC50 :
-
Half maximal effective concentration
- ELISA:
-
Enzyme-linked immunosorbent assay
- HIV:
-
Human immunodeficiency virus
- IC50 :
-
Half-maximal inhibitory concentration
- LTA:
-
Light transmission aggregometry
- PAR-4 agonist:
-
Proteinase-activated receptor-4 agonist
- PARs:
-
Protease-activated receptors
- PBS:
-
Phosphate-buffered saline
- PM:
-
Prasugrel metabolite
- PRP:
-
Platelet-rich plasma
- TP receptor:
-
Thromboxane A2 receptor
- TRAP:
-
Thrombin receptor-activating peptide
- TXA2/TXB2 :
-
Thromboxane A2/thromboxane B2
- U46619:
-
Stable thromboxane A2 receptor agonist
- VWD:
-
Von Willebrand disease
- VWF:
-
Von Willebrand factor
- VWF: RCo:
-
Ristocetin cofactor assay
References
Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961;192:531–2.
Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br J Haematol. 1961;7:42–50.
Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927–9.
Born GV, Cross MJ. The aggregation of blood platelets. J Physiol. 1963;168(1):178–95.
O’Brien JR. Platelet aggregation: part II. Some results of an new method of study. J Clin Pathol. 1962;15(5):452–55.
Zucker MB. Platelet aggregation measured by the photometric method. Methods Enzymol. 1989;169:117–33.
Gresele P, Harrison P, Bury L, Falcinelli E, Gachet C, Hayward CP, et al. Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost. 2014;12(9):1562–9.
Alessi MC, Sie P, Payrastre B. Strengths and weaknesses of light transmission aggregometry in diagnosing Hereditary platelet function disorders. J Clin Med. 2020;9(3):763.
Gresele P, Falcinelli E, Bury L. Laboratory diagnosis of clinically relevant platelet function disorders. Int J Lab Hematol. 2018;40(Suppl 1):34–45.
Le Blanc J, Mullier F, Vayne C, Lordkipanidze M. Advances in platelet function testing-light transmission aggregometry and Beyond. J Clin Med. 2020;9(8):2636.
Larsen JB, Hvas AM, Hojbjerg JA. Platelet function testing: update and future directions. Semin Thromb Hemost. 2023;49(6):600–8.
Lordkipanidze M, Lowe GC, Kirkby NS, Chan MV, Lundberg MH, Morgan NV, et al. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood. 2014;123(8):e11–22.
Hsu H, Chan MV, Armstrong PC, Crescente M, Donikian D, Kondo M, et al. A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia. Pathology. 2022;54(6):746–54.
Armstrong PC, Truss NJ, Ali FY, Dhanji AA, Vojnovic I, Zain ZN, et al. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2. J Thromb Haemost. 2008;6(11):1933–43.
Chan MV, Armstrong PC, Papalia F, Kirkby NS, Warner TD. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. Platelets. 2011;22(7):485–94.
Tamang HK, Stringham EN, Tourdot BE. Platelet functional testing Via High-Throughput Microtiter plate-based assays. Curr Protoc. 2023;3(2):e668.
Fratantoni JC, Poindexter BJ. Measuring platelet aggregation with microplate reader. A new technical approach to platelet aggregation studies. Am J Clin Pathol. 1990;94(5):613–7.
Bednar B, Condra C, Gould RJ, Connolly TM. Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists. Thromb Res. 1995;77(5):453–63.
Walkowiak B, Kesy A, Michalec L. Microplate reader–a convenient tool in studies of blood coagulation. Thromb Res. 1997;87(1):95–103.
Krause S, Scholz T, Temmler U, Losche W. Monitoring the effects of platelet glycoprotein IIb/IIIa antagonists with a microtiter plate method for detection of platelet aggregation. Platelets. 2001;12(7):423–30.
Salmon DM. Optimisation of platelet aggregometry utilising micotitreplate technology and integrated software. Thromb Res. 1996;84(3):213–6.
Hoylaerts MF, Thys C, Stassen JM, Vermylen J. Dose-responses to inducers and inhibitors of platelet aggregation analysed via a micro-method. Blood Coagul Fibrinolysis. 1996;7(2):187–90.
Ali FY, Armstrong PC, Dhanji AR, Tucker AT, Paul-Clark MJ, Mitchell JA, et al. Antiplatelet actions of statins and fibrates are mediated by PPARs. Arterioscler Thromb Vasc Biol. 2009;29(5):706–11.
Chan MV, Warner TD. Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readings. Platelets. 2012;23(5):404–8.
Chan MV, Lordkipanidze M, Warner TD. Assessment of platelet function by high-throughput screening light transmission aggregometry: Optimul Assay. Methods Mol Biol. 2023;2663:627–36.
Peace AJ, Tedesco AF, Foley DP, Dicker P, Berndt MC, Kenny D. Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease. J Thromb Haemost. 2008;6(12):2027–34.
Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, et al. Recommendations for the standardization of light transmission aggregometry: a Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost. 2013;11(6):1183–9.
Vinholt PJ, Nybo M, Nielsen CB, Hvas AM. Light transmission aggregometry using pre-coated microtiter plates and a Victor X5 plate reader. PLoS ONE. 2017;12(10):e0185675.
Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem. 1994;216(2):444–50.
Armstrong PC, Dhanji AR, Truss NJ, Zain ZN, Tucker AT, Mitchell JA, et al. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness. Thromb Haemost. 2009;102(4):772–8.
Nowak J, Watala C, Boncler M. Antibody binding, platelet adhesion, and protein adsorption on various polymer surfaces. Blood Coagul Fibrinolysis. 2014;25(1):52–60.
Boncler M. A commercial nonbinding surface effectively reduces Fibrinogen Adsorption but does not prevent platelet adhesion to Fibrinogen. Macromol Biosci. 2023;23(7):e2300052.
Chan MV, Armstrong PC, Warner TD. 96-well plate-based aggregometry. Platelets. 2018;29(7):650–5.
Dunster JL, Bye AP, Kriek N, Sage T, Mitchell JL, Kempster C, et al. Multiparameter phenotyping of platelet reactivity for stratification of human cohorts. Blood Adv. 2021;5(20):4017–30.
Maayani S, Schwarz T, Martinez R, Tagliente TM. Activation of Gi-coupled receptors releases a tonic state of inhibited platelet aggregation. Platelets. 2001;12(2):94–8.
Ramsey R, Evatt BL. Rapid assay for Von Willebrand factor activity using formalin-fixed platelets and microtitration technic. Am J Clin Pathol. 1979;72(6):996–9.
Truss NJ, Beavis J, MacCallum PK, Harrison P, Warner TD. Rapid and accurate method for the Von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates. J Thromb Haemost. 2009;7(7):1226–8.
Favaloro EJ. Diagnosis or exclusion of Von Willebrand Disease using Laboratory Testing. Methods Mol Biol. 2017;1646:391–402.
Jarantow SW, Pisors ED, Chiu ML. Introduction to the Use of Linear and Nonlinear Regression Analysis in quantitative biological assays. Curr Protoc. 2023;3(6):e801.
Sebaugh JL. Guidelines for accurate EC50/IC50 estimation. Pharm Stat. 2011;10(2):128–34.
Armstrong PC, Leadbeater PD, Chan MV, Kirkby NS, Jakubowski JA, Mitchell JA, et al. In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation. J Thromb Haemost. 2011;9(3):552–61.
Chan MV, Leadbeater PD, Watson SP, Warner TD. Not all light transmission aggregation assays are created equal: qualitative differences between light transmission and 96-well plate aggregometry. Platelets. 2018;29(7):686–9.
Moran N, Kiernan A, Dunne E, Edwards RJ, Shields DC, Kenny D. Monitoring modulators of platelet aggregation in a microtiter plate assay. Anal Biochem. 2006;357(1):77–84.
Sun P, McMillan-Ward E, Mian R, Israels SJ. Comparison of light transmission aggregometry and multiple electrode aggregometry for the evaluation of patients with mucocutaneous bleeding. Int J Lab Hematol. 2019;41(1):133–40.
Sharma P, Sachdeva MUS, Kumar N, Bose S, Bose P, Uppal V, et al. A comparative study between light transmission aggregometry and flow cytometric platelet aggregation test for the identification of platelet function defects in patients with bleeding. Blood Res. 2021;56(2):109–18.
Kirkby NS, Leadbeater PD, Chan MV, Nylander S, Mitchell JA, Warner TD. Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel. J Thromb Haemost. 2011;9(10):2103–5.
Lundberg Slingsby MH, Gliemann L, Thrane M, Rytter N, Egelund J, Chan MV, et al. Platelet responses to pharmacological and physiological interventions in middle-aged men with different habitual physical activity levels. Acta Physiol (Oxf). 2018;223(1):e13028.
Rauzi F, Kirkby NS, Edin ML, Whiteford J, Zeldin DC, Mitchell JA, et al. Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1. FASEB J. 2016;30(12):4256–66.
Shih CC, Chan MV, Kirkby NS, Vojnovic I, Mitchell JA, Armstrong PC, et al. Platelet inhibition by P2Y12 antagonists is potentiated by adenosine signalling activators. Br J Pharmacol. 2021;178(23):4758–71.
Leadbeater PD, Kirkby NS, Thomas S, Dhanji AR, Tucker AT, Milne GL, et al. Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel. J Thromb Haemost. 2011;9(10):2050–6.
Scharf RE. Drugs that affect platelet function. Semin Thromb Hemost. 2012;38(8):865–83.
Ahmetaj-Shala B, Tesfai A, Constantinou C, Leszczynski R, Chan MV, Gashaw H, et al. Pharmacological assessment of ibuprofen arginate on platelet aggregation and colon cancer cell killing. Biochem Biophys Res Commun. 2017;484(4):762–6.
Nielsen CB, Nielsen C, Nybo M, Just SA, Vinholt PJ. The in vitro effect of antirheumatic drugs on platelet function. Platelets. 2020;31(2):248–57.
Vinholt PJ, Nielsen C, Soderstrom AC, Brandes A, Nybo M. Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner. J Thromb Thrombolysis. 2017;44(2):216–22.
Knudsen GH, Nielsen C, Nielsen CB, Frederiksen H, Vinholt PJ. The effect of mycophenolate mofetil on platelet function. Blood Coagul Fibrinolysis. 2020;31(2):132–9.
Grech J, Chan MV, Ochin C, Lachapelle A, Thibord F, Schneider Z, et al. Serotonin-affecting antidepressant use in relation to platelet reactivity. Clin Pharmacol Ther. 2022;111(4):909–18.
Mac Mullan PA, Peace AJ, Madigan AM, Tedesco AF, Kenny D, McCarthy GM. Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: a novel finding and potential therapeutic target. Rheumatology (Oxford). 2010;49(2):240–5.
Satchell CS, O’Halloran JA, Cotter AG, Peace AJ, O’Connor EF, Tedesco AF, et al. Increased platelet reactivity in HIV-1-infected patients receiving abacavir-containing antiretroviral therapy. J Infect Dis. 2011;204(8):1202–10.
Cooke NM, Egan K, McFadden S, Grogan L, Breathnach OS, O’Leary J, et al. Increased platelet reactivity in patients with late-stage metastatic cancer. Cancer Med. 2013;2(4):564–70.
Kring C, Rasmussen LM, Lindholt JS, Diederichsen ACP, Vinholt PJ. Platelet aggregation is not altered among men with diabetes mellitus. Acta Diabetol. 2020;57(4):389–99.
Cunha J, Chan MV, Nkambule BB, Thibord F, Lachapelle A, Pashek RE, et al. Trends among platelet function, arterial calcium, and vascular function measures. Platelets. 2023;34(1):2238835.
Frelinger AL 3rd, Rivera J, Connor DE, Freson K, Greinacher A, Harrison P, et al. Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: communication from the ISTH SSC Subcommittee on platelet physiology. J Thromb Haemost. 2021;19(12):3193–202.
Mangin PH, Gardiner EE, Nesbitt WS, Kerrigan SW, Korin N, Lam WA, et al. In vitro flow based systems to study platelet function and thrombus formation: recommendations for standardization: communication from the SSC on Biorheology of the ISTH. J Thromb Haemost. 2020;18(3):748–52.
Alessi MC, Coxon C, Ibrahim-Kosta M, Bacci M, Voisin S, Rivera J, et al. Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on platelet physiology. J Thromb Haemost. 2023;21(9):2596–610.
Pastakia KB, Brownson NE, Terle DA, Poindexter BJ. Amphotericin B induced abnormalities in human platelets. Clin Mol Pathol. 1996;49(5):M301–7.
Acknowledgements
The authors thank E. Lowczowski, B.Sc., Medical University of Łódź, for proofreading the article. Funding for this project was provided by the Medical University of Łódź (503/6-020-01/503-61-001-19-00).
Author information
Authors and Affiliations
Contributions
MB: Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft preparation; JG: Investigation, Writing – review & editing.
Corresponding author
Ethics declarations
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Boncler, M., Golański, J. The study of platelet aggregation using a microtiter plate reader ‒ methodological considerations. Pharmacol. Rep 76, 328–337 (2024). https://doi.org/10.1007/s43440-024-00576-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43440-024-00576-7